Moreover, recent studies have demonstrated that several useful biomarkers, such as CK-18 and fetuin-A, may reflect apoptosis, necrosis of hepatocytes, as well as disease severity in NAFLD [34,35]. Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.